Sánchez-Fayos Calabuig P, Hernández Guío C, Porres Cubero J C, Olavarría López-Aróstegui E, Rivas Manga C, Outeiriño Hernanz J, Sánchez Fayos J
Servicio de Aparato Digestivo, Fundación Jiménez Díaz, Madrid.
Sangre (Barc). 1995 Dec;40(6):485-9.
Immunoproliferative small intestine disease (IPSID) encompasses a primary intestinal lymphoma of underpriviliged populations of North Africa, Middle East, etc. This epidemiological feature strongly implicates environmental and host (genetic) factors in its pathogenesis. IPSID can be distinguished on clinicopathological grounds from "Western-type" intestinal lymphomas. "IPSID-like" lymphomas had been sporadically identified, i.e., patients with original clinico-analytical data of IPSID (chronic diarrhoea, malabsortion, clubbing of fingers, diffuse intestinal involvement, etc.) without its conventional histopathologic (lymphoplasmocytic or plasmocytic infiltration) and immunological (alpha-heavy-chain paraprotein) background.
The aim of this study has been: 1) to identify, in a series of small intestine lymphomas, a group of patients with a long-lasting history of chronic diarrhoea and a clinico-biologic pattern of "IPSID-like" lymphoma; 2) to analyze its clinicopathological profile; 3) to search for differences with the pattern of the remaining cases ("Western-type" lymphomas) and 4) To suggest a possible epidemiological significance.
Patients considered were 12 Spanish caucasians with primary intestinal lymphoma and a long-lasting history of chronic diarrhoea vs 31 cases of "Western-type" intestinal lymphomas admitted in our Hospital over a 33-year period. Statistical significance of differences in clinico-biological features (symptoms/signs, analytical data, patterns of involvement, histopathology, immunophenotype and tumor staging) between these two groups was evaluated using X2 test.
The results of this retrospective study allow us to delineate a relatively homogeneous "IPSID-like" group (12 cases) among 43 cases of primary small intestine lymphoma diagnosed between 1960 and 1993. The clinico-pathological behavior of these patients was significantly different from that exhibited by the 31 cases of so-called "Western-type" lymphomas.
It is suggested that they may represent a group of patients suffering an evanescent "IPSID-equivalent" disorder (last case diagnosed in 1975), that probably has evolved in similar but not identical epidemiological circumstances to those present in the "Third World" countries of our Mediterranean area.
免疫增殖性小肠疾病(IPSID)包括北非、中东等贫困人群中的原发性肠道淋巴瘤。这一流行病学特征强烈提示环境和宿主(遗传)因素在其发病机制中起作用。IPSID可根据临床病理学特征与“西方型”肠道淋巴瘤相鉴别。“IPSID样”淋巴瘤已被零星发现,即具有IPSID原始临床分析数据(慢性腹泻、吸收不良、杵状指、弥漫性肠道受累等)但无传统组织病理学(淋巴浆细胞或浆细胞浸润)和免疫学(α重链副蛋白)背景的患者。
本研究的目的是:1)在一系列小肠淋巴瘤患者中,识别出一组有长期慢性腹泻病史且具有“IPSID样”淋巴瘤临床生物学模式的患者;2)分析其临床病理特征;3)寻找与其余病例(“西方型”淋巴瘤)模式的差异;4)提出可能的流行病学意义。
研究对象为12例患有原发性肠道淋巴瘤且有长期慢性腹泻病史的西班牙白种人,与我院33年间收治的31例“西方型”肠道淋巴瘤患者进行对比。使用X²检验评估两组临床生物学特征(症状/体征、分析数据、受累模式、组织病理学、免疫表型和肿瘤分期)差异的统计学意义。
这项回顾性研究的结果使我们能够在1960年至1993年间诊断的43例原发性小肠淋巴瘤中勾勒出一个相对同质的“IPSID样”组(12例)。这些患者的临床病理行为与31例所谓“西方型”淋巴瘤显著不同。
提示它们可能代表一组患有短暂“IPSID等效”疾病的患者(最后一例于1975年诊断),其发病可能与我们地中海地区“第三世界”国家类似但不完全相同的流行病学情况有关。